Truist cuts Boston Scientific target to $62, maintains Buy
Truist Securities analyst Richard Newitter maintained a Buy rating on Boston Scientific but lowered the price target to $62 from $64, reflecting a revised valuation outlook. This move aligns with a broader trend of downward target adjustments by other firms, including Mizuho, RBC Capital, and Needham, despite continued positive ratings.
*this image is generated using AI for illustrative purposes only.
Truist Securities analyst Richard Newitter has maintained a Buy rating for Boston Scientific while lowering the price target to $62, down from the previous $64. This adjustment reflects a revised valuation outlook for the medical device company. The decision follows a broader trend of recalibrated expectations across the sector, with other firms also scaling back near-term targets despite positive ratings.
The reduction in the price target contrasts with the continued Buy recommendation, indicating that while the stock is still expected to perform well, the near-term valuation has been adjusted. This aligns with similar actions by other analysts who have maintained positive stances but revised their price objectives downward.
| Firm | Rating | New Price Target | Previous Price Target |
|---|---|---|---|
| Truist Securities | Buy | $62 | $64 |
| Mizuho | Outperform | $70 | $90 |
| RBC Capital | Outperform | $85 | $100 |
| Needham | Buy | $57 | $77 |
| Evercore ISI Group | Outperform | $65 | $78 |
Boston Scientific continues to receive endorsements from analysts, though the consensus on price targets is shifting lower across the board.
What specific factors are driving the sector-wide recalibration of valuation multiples for medical device companies?
How long might it take for Boston Scientific to bridge the gap between the current trading price and the new consensus targets?
Could the divergence between Buy ratings and lowered price targets signal a temporary sector-wide correction rather than company-specific issues?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
